Knowde Enhanced TDS
Identification & Functionality
- Carrier
- INCI Name
- Ingredient Origin
- Cosmetic Ingredients Functions
- CAS No.
- 8013-17-0
- EC No.
- 232-393-1
- Technologies
- Product Families
Features & Benefits
- Benefit Claims
- Labeling Claims
- Product Background
The Schizandra sphenanthera berries used to make SWEETONE® grow wild, without pesticides or fertilizers, and are harvested by hand according to best agricultural practices. As a part of its commitment to fighting bio-piracy, Expanscience has documented the traditional knowledge associated with Schizandra sphenanthera berries to avoid any conflict with the use of biodiversity.
Dual action: soothing and unifying for a skin clear of imperfections Perfect skin has become a universal quest. Today, women are looking for a miracle ingredient that can erase all the skin imperfections that appear due to the pressures of modern life (stress and fatigue) and environmental factors (pollution, tobacco, sun exposure, etc.). Sensitive skin concern, which affects two out of three women, also causes imperfections.
Skin imperfections include redness, small pimples, flushing, uneven skin tone, sun spots and discomfort, irritation or burning.
- General Information
• Solubility: hydrosoluble
• Recommended formulation temperature: add during cooling, at 35°C to 40°C
• pH of the aqueous solution (5% powder): 3.5 to 4.5
• Storage: between 15°C and 25°C, in an airtight sachet, protected from light and humidity
• Patents: WO2011012612, 30/07/2009 - WO2011012615, 30/07/2009 FR14 61 518, 26/11/2014
Applications & Uses
- Markets
- Color Cosmetic Applications
- Sun Care Applications
- Treatment Product Applications
- Use Level
- 0.1% to 0.5%
- Recommended Uses
• Imperfection corrector (skin-tone unifying treatment, BB-CC cream)
• Soothing, anti-redness treatment for sensitive skin
• After-sun treatment
Properties
- Odor
- Characteristic
- Soluble in
- Water
Regulatory & Compliance
- Certifications & Compliance
Technical Details & Test Data
- Efficacy Study
Effectiveness in-vitro
Soothing effect: SWEETONE® globally modulates inflammation
Action on non-specific, vascular and neurogenic inflammation (in-vitro tests, 0.05% Hydrolysate of Schizandra 0.1% SWEETONE®)
*keratinocytes, PMA stress (Phorbol Myristate Acetate) ** endothelial cells proliferation (vaisseaux), VEGF stress *** neurones/keratinocytes co-culture, capsaicin stress
*keratinocytes, PMA stress (Phorbol Myristate Acetate)
** endothelial cells proliferation (vaisseaux), VEGF stress
*** neurones/keratinocytes co-culture, capsaicin stress
SWEETONE® modulates non-specific and vascular inflammation to limit the proliferation of endothelial cells and reduces skin imperfections, such as redness. By reducing neurogenic inflammation, SWEETONE® soothes the sensitive skins.
Unifying effect: SWEETONE® can modulate melanogenesis
The effects of ultraviolet light, the aging process and inflammatory stress can all result in pigmentation disorders. SWEETONE® is able to modulate these pigmentation disorders thanks to the
• effect it has on limiting the synthesis of melanin: -25% (in-vitro test, melanocytes, 0.05% HS)
• effect it has on the dendricity of melanocytes: inhibits the release of PGE2 (-35%, in-vitro test, keratinocytes, 0.05%HS). PGE2, a lipid inflammation mediator, stimulates the dendricity of melanocytes, increasing the transfer of melanocyte melanin to the keratinocytes. As such, SWEETONE® can potentially limit the spread of melanin in skin.
- Clinical study
Most non-homogenous complexions are caused by skin redness. Using a randomized clinical trial, double-blind versus placebo, the benefits of SWEETONE® in reducing redness and creating a more uniform complexion is demonstrated. The assessment was carried out using an innovative technique that involved analyzing images from photos taken in cross polarized light.
60 women (average age 36), divided into 2 homogenous groups, with sensitive skin and established redness, applied a cream containing either 0.5% SWEETONE® or the placebo for a period of 56 days. The cream was applied twice per day.
Ability to reduce redness: measurement of the surface area covered by the blood vessels
Ability to homogenize the complexion: measurement of contrast Reducing contrast results in a more uniform complexion.
•Self-assessment (% of satisfaction after 56 days): The results obtained are confirmed by the volunteers: Sweetone® limits the appearance of newly diffused redness 83 % Sweetone® reduces the intensity of diffused redness 76 % Sweetone® limits the appearance of new localized redness 69%
- Assays content
Assay Content Alpha-amino nitrogen content/DM 1.0 to 4.0 g/100 g Protides by Kjeldahl 3.0 to 9.0% Citric acid content/DM min.5.0% Maltodextrin content/ DM 45.0 to 55.0 g/100 g Total sugars content/DM min.55.0 g/100 g